IPOs To Watch, WBD Rejects Paramount & Betting on Prediction Markets 12/17/25
As Medlife opens at $6/share above its IPO price, we break down the big offerings to watch in 2026. The Warner Bros. Discovery Board unanimously votes to reject Paramount's hostile bid in favor of Netflix's offer. Plus, the fintech company that's expanding its prediction market offerings.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
As Medlife opens at $6/share above its IPO price, we break down the big offerings to watch in 2026. The Warner Bros. Discovery Board unanimously votes to reject Paramount's hostile bid in favor of Netflix's offer. Plus, the fintech company that's expanding its prediction market offerings.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.